57 (PB045): Individualised schedule optimisation improves rates and severity of anaemia in patients (pts) treated with lunresertib (lunre), a PKMYT1 inhibitor, and camonsertib (cam... by Hojgaard, M., Yap, T.A., Lee, E.K., Weiss, M.C., Lheureux, S., Simpkins, F., LoRusso, P., Carneiro, B.A., Moy, R.H., Aguado-Fraile, E., Sethuraman, S., Soria-Bretones, I., Liu, Y., Sun, X., Hawkey, N., Basciano, P., Unger, T.J., Bacqué, E.S., Schram, A.

Get full text